University of Arkansas: all 398 studies

Page 4 of 4. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• Is a Smartphone Application Effective as an Oral Medication Adherence AidTerminatedNCT01968876Early Phase 1
• Evaluation of a Microendoscopic Imaging System in Examination of Resected TissuesTerminatedNCT01968863
• Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor TherapyWithdrawnNCT01967927Early Phase 1
• Improving Anticoagulant Therapy Through Warfarin Metabolite ProfilingCompletedNCT01964794
• The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
• A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)WithdrawnNCT01820312Phase 2
• Sutures vs. Staples Skin Closure After C-section in Obese PatientsTerminatedNCT01820221Not applicable
• A Phase I Clinical Trial of an HPV Therapeutic VaccineCompletedNCT01653249Phase 1
• Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung CancerWithdrawnNCT01637376Phase 1
• UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer PatientsWithdrawnNCT01622595
• Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple MyelomaCompletedNCT01622582
• Effects of a Breakfast and Snack on Cognitive Function in PreadolescentsWithdrawnNCT01592487
• Surgeon Compared to Nuclear Radiology Readers for Tc-99m Sestamibi Scans for Parathyroid DiseaseCompletedNCT01545622
• Complications of Endocrine Surgery: Data From the United HealthSystem ConsortiumCompletedNCT01539499
• Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive ParathyroidectomyCompletedNCT01539486
• Effect of Tai Chi on Osteoarthritic Knee Pain in Elders With Mild DementiaCompletedNCT01528566Not applicable
• Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate CancerActive, not recruitingNCT01514669
• The Use of Prophylactic Antibiotics in Isolated Blowout FracturesWithdrawnNCT01504568Not applicable
• Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon CancerCompletedNCT01479894
• Translating the Diabetes Prevention Program (DPP) Lifestyle Intervention to Rural African-American Communities (HEALTHY Ways)CompletedNCT01472588Phase 2
• Body Composition of Infants: Follow-up to Placenta and Cord Blood AnalysesWithdrawnNCT01464684
• Systemic Dickkopf-related Protein 1 (DKK1)During Estrogen Level Changes in Post-menopausal Breast Cancer Patients Treated With Aromatase InhibitorsCompletedNCT01431872
• Impact of Dance Therapy on Parkinson's DiseaseWithdrawnNCT01428648Not applicable
• Telemedicine Versus Traditional Treatment of Muscle Tension DysphoniaCompletedNCT01419444Phase 1/2
• Nutrient Synergy in Beef and Stimulation of Protein Synthesis in ElderlyCompletedNCT01415973Not applicable
• Assessment of Fat Free Mass Index and Its Impact on Health in Children With Cystic FibrosisCompletedNCT01401439
• Translation of Obesity and Cognitive Program by Lay Health EducatorsCompletedNCT01377506Not applicable
• Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy ControlsCompletedNCT01331980
• A Study Evaluating Hypotension and Autonomic Nervous System Dysfunction in Multiple Myeloma (MM) PatientsStatus unknownNCT01314625
• Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive AspergillosisWithdrawnNCT01207128Phase 2
• Specimen X-Rays of Removed Axillary Lymph Nodes to Guide Pathological SamplingCompletedNCT01156454
• Excision Followed by Radiofrequency Ablation for Breast CancerActive, not recruitingNCT01153035Not applicable
• Effects of Amino Acids on Regional Lipid MetabolismCompletedNCT01150188Not applicable
• Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn ModelCompletedNCT01148121Not applicable
• Deep Sequencing of the Breast Cancer TranscriptomeWithdrawnNCT01141530
• Low Density Lipoprotein Cholesterol (CLDL) as a Cardiovascular Disease Risk Factor in Rheumatoid ArthritisCompletedNCT01105715
• Transcranial Magnetic Stimulation of the Prefrontal Cortex: Effects on Risky Decision Making and Temporal Discounting.WithdrawnNCT01098864Not applicable
• Drug Discrimination in Methadone-Maintained Humans Study 3CompletedNCT01068847Phase 1
• Tissue Sectioning by Electro-DissociationWithdrawnNCT01054612
• Oral Mucositis in Patients Undergoing Antineoplastic ChemotherapyCompletedNCT01036633
• Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma SubjectsTerminatedNCT01018927
• The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic LeukemiaTerminatedNCT01010256
• UARK 2009-32 Compassionate Use Study of CarfilzomibNo longer availableNCT00999414
• Effects of PS-IPC Supplementation on Muscle Mass and Functional Outcomes in Older AdultsTerminatedNCT00926250Not applicable
• Biotin Status in PregnancyCompletedNCT00894920Not applicable
• Panobinostat/Velcade in Multiple MyelomaTerminatedNCT00891033Phase 1
• Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior TherapyActive, not recruitingNCT00871013Phase 2
• UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionActive, not recruitingNCT00869232Phase 2
• Airway Vascular LesionsCompletedNCT00866827
• A Preliminary Study Utilizing a Flexible Endoscope for Pelvic CuldoscopyTerminatedNCT00848575
• UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk MyelomaActive, not recruitingNCT00734877Phase 3
• Drug Discrimination in Methadone-Maintained Humans Study 2CompletedNCT00733239Phase 1
• Drug Discrimination in Methadone-Maintained Humans Study 1CompletedNCT00593463Phase 1
• Effect of Changing Diet on Fasting and Post Fat Load LipoproteinsCompletedNCT00593424Not applicable
• Bisphosphonate-Associated Jaw Osteonecrosis and PET ImagingCompletedNCT00592982
• Thyroid Disease Serum RepositoryCompletedNCT00592605
• Thyroid Dysfunction in Head and Neck Surgery PatientsCompletedNCT00592514
• Head and Neck Cancer Screening and Serum RepositoryCompletedNCT00592371
• Regulation of Cerebral Blood Flow in Very Low Birth Weight InfantsCompletedNCT00579943
• Histologic Diagnoses of Incidentally Detected Lesions on MRIWithdrawnNCT00579735
• Use of Breast MRI for Local StagingWithdrawnNCT00579319
• UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological MalignanciesWithdrawnNCT00578045Phase 1
• Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving ChemoradiationCompletedNCT00577902
• A Pilot Study of the Combination of Melphalan, Bortezomib, Thalidomide and Dexamethasone (MEL-VTD)WithdrawnNCT00577668Phase 2
• Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic FibrosisTerminatedNCT00577499
• Diagnosis of Hemangiomas and Vascular MalformationsCompletedNCT00577213
• Hydralazine as Demethylating Agent in Breast CancerWithdrawnNCT00575978Phase 1/2
• Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye ConfirmationCompletedNCT00575744Phase 2
• Hydralazine as a Demethylating Agent in Rectal CancerWithdrawnNCT00575640Phase 1/2
• Analyzing the Composition of Tears to Identify CancerCompletedNCT00574678Phase 1/2
• Percutaneous Removal and Margin Ablation for Breast CancerCompletedNCT00574301Phase 1/2
• Axillary Reverse MappingActive, not recruitingNCT00572481Phase 2
• Therapeutic Research in Multiple MyelomaCompletedNCT00572338
• Glucocorticoids Promote Osteoclast SurvivalTerminatedNCT00572299
• UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total TherapyActive, not recruitingNCT00572169Phase 3
• Effect of Thiazolidinedione Treatment Vascular Risk MarkersCompletedNCT00571506Phase 4
• Methamphetamine-Quetiapine Interactions in HumansTerminatedNCT00567866Early Phase 1
• Efficacy of Ketamine in Children With Severe Brain Injury for Brain Cell ProtectionWithdrawnNCT00556387Phase 2
• Tissue Lipids and Insulin ResistanceWithdrawnNCT00483210Not applicable
• Combined Effects of Nutritional and Exercise CountermeasuresCompletedNCT00447044Not applicable
• Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer PatientsCompletedNCT00446888Not applicable
• Telemedicine-Based Collaborative Care to Reduce Rural DisparitiesCompletedNCT00439452Not applicable
• Disulfiram for Treating Cocaine Dependence in Individuals Maintained on MethadoneCompletedNCT00218608Phase 2
• UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple MyelomaCompletedNCT00113932Phase 2
• UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory PatientsCompletedNCT00111748Phase 3
• Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy IICompletedNCT00093028Phase 3
• Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell TransplantCompletedNCT00089453Phase 1
• Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage TherapyCompletedNCT00083902Phase 2
• D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple MyelomaCompletedNCT00083876Phase 3
• Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00083707Phase 2
• Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory LeukemiaCompletedNCT00083694Phase 2
• DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation RelapseCompletedNCT00083681Phase 2
• Anti-Angiogenesis Therapy Using Thalidomide in Multiple MyelomaCompletedNCT00083577Phase 2
• Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or IntranodallyCompletedNCT00083538Phase 2
• Study of Combination PS-341 and Thalidomide in Multiple MyelomaCompletedNCT00083460Phase 1
• Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and ThalidomideCompletedNCT00083408Phase 2
• An Open Protocol for the Compassionate Use of ThalidomideCompletedNCT00081757Phase 1/2
• Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's DiseaseCompletedNCT00002652Phase 2

← University of Arkansas overview and focus areas